|
Volumn 10, Issue 14, 2000, Pages 1567-1570
|
The design and synthesis of thrombin inhibitors: The introduction of in vivo efficacy and oral bioavailability into benzthiazolylalanine inhibitors
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALANINE DERIVATIVE;
CGH 1484;
CGH 752;
QUINOLINE DERIVATIVE;
THROMBIN INHIBITOR;
UNCLASSIFIED DRUG;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANIMAL TISSUE;
AORTA THROMBOSIS;
ARTICLE;
DOSE RESPONSE;
DRUG BIOAVAILABILITY;
DRUG DESIGN;
DRUG EFFICACY;
DRUG INHIBITION;
DRUG SYNTHESIS;
IN VIVO STUDY;
NONHUMAN;
RAT;
STRUCTURE ACTIVITY RELATION;
ADMINISTRATION, ORAL;
ALANINE;
ANIMALS;
ANTITHROMBINS;
BIOLOGICAL AVAILABILITY;
CHYMOTRYPSIN;
DRUG DESIGN;
KINETICS;
MOLECULAR CONFORMATION;
MOLECULAR STRUCTURE;
PARTIAL THROMBOPLASTIN TIME;
PLASMIN;
STRUCTURE-ACTIVITY RELATIONSHIP;
SULFONAMIDES;
THIAZOLES;
THROMBOSIS;
TRYPSIN;
|
EID: 0034679838
PISSN: 0960894X
EISSN: None
Source Type: Journal
DOI: 10.1016/S0960-894X(00)00283-3 Document Type: Article |
Times cited : (8)
|
References (12)
|